TB Events World TB Day 2008 TB & WHO TB Fact Sheet TB Forum Global TB TB & HIV TB & Diabetes TB & Poverty TB & Women TB & Children TB News TB & DOTS TB & Famous Personalities
Sitemap


CONTROL PROGRAMS

Putting brakes on TB

With the implementation of Revised National Tuberculosis Programme (RNTCP), the health department has begun making efforts to check the cases of tuberculosis (TB) in the region. The health officials are reaching out to villagers with information on latest TB cure measures. People are being asked to visit health centres if they have any symptoms of the disease.

The department is putting special emphasis on DOTS (directly observed treatment short course). Claiming that a number of villagers are coming forward to get themselves treated under DOTS method, senior health officials have told health workers to widen their reach so that people with TB symptoms can be examined and treated accordingly.

According to estimates, over 3,000 persons are being treated under DOTS method in rural and semi-urban pockets.

The health department has set up over 570 DOTS centres in the district at various primary health centres, community health centres and government\district hospitals with around 200 ASHA DOTS providers aiding in the programme.

Chief medical officer Dr Pradeep Kumar Sinha said villagers are gradually opening to the programme and added that those with TB symptoms have begin approaching DOTS centres.

Meanwhile, sources in health department disclosed that the patients are being places under three categories. They have been offered coloured boxes having their medicines, advice and prescriptions regarding mentioning of dates and time for the consumption of medicines.

Under the DOTS method, patients are given medicines on alternate days. If the treatment is followed regularly then the disease may be cured in six to 12 months. Health officials have advised that if a person shows symptoms like prolonged cough, fever, chest pain and vomiting blood, he should visit the nearest DOTS centre for a thorough examination.

As part of the examination, a patient's sputum is tested for TB at DOTS centres. This, the CMO said, is the most effective tool in detecting the disease.

Fact File
  • TB is a common and infectious disease caused by myco-bacteria. It mainly attacks the lungs but can also affect the central nervous system, lymphatic, circulatory system, bones, joints and even the skin.
  • When persons with active TB cough, sneeze, speak, they expel an infectious aerosol. For instance, a single sneeze can release up to 40,000 droplets and each of these droplets can transmit the disease.
  • A patient suffering from TB could affect at least 14 persons while coughing at public places. Most of the patients in city and rural areas have lungs TB.
  • About 49 district microscopic centres including 45 government and 4 NGOs are active in the district where persons with TB symptoms are examined for the disease.
  • Maximum TB cases are reported from Shankargarh, Kaudhiyara, Lalapur, Meja, Daraganj in the district.
DOTS IS A SYSTEMATIC PLAN TO CHECK TB IN FIVE STAGES
  • Administrative assurance: TB is the leading infectious cause of death among adults. TB kills more men than women, yet more women die of TB than all causes associated with childbirth combined. Since TB can be cured and the epidemic reversed, it warrants top most priority, which it has been accorded to by the Central government.
  • Quality diagnosis needed: Quality microscopy allows health workers to go through the tubercle bacilli and is essential to identify the infectious patients who need treatment at the earliest.
  • Quality drugs: An incessant delivery of quality anti-TB drugs must be available at health centres. In the RNTCP, a box of medications for the entire treatment is earmarked for every patient registered, ensuring the availability of the full course of treatment the moment a patient is initiated on treatment. Hence, in DOTS, the treatment can never interrupt for lack of medicines.
  • Supervised treatment to ensure the right treatment, given in the right way. RNTCP uses best anti-TB medications available. But unless treatment is made convenient for patients, it will fail.

Source

New Smear Positive Case
Detection Rate of India
Third quarter, 2008

Population in India covered under DOTS and total Tuberculosis patients put on treatment each quarter



NGO to ask MPs on steps they took to control tuberculosis

March 5th, 2009
An NGO, working for tuberculosis patients, has initiated a study to know steps taken by parliamentarians to control the disease in their constituencies.

“With nearly 1,000 people dying of tuberculosis everyday in India despite several high quality drugs and well established programmes, it become important to know what people’s representatives are doing to control and spread awareness about it,” said Bobby John of the NGO Advocacy to Control TB Internationally (Action) Thursday.

The NGO will send a questionnaire to all members of 14th Lok Sabha seeking information regarding steps taken by them to spread awareness about tuberculosis.

 “Political will is required to ensure that treatment facilities are easily available to tuberculosis patients as majority of people suffering from the disease are not able to get treatment,” said John.

The data will then be collated and a report will be prepared that will be handed to the government to ensure parliamentarians are involved in tuberculosis awareness programme.

Source: http://www.thaindian.com/newsportal/uncategorized/ngo-to-ask-mps-on-steps-they-took-to-control-tuberculosis_100163074.html

RNTCP performance in 3rd quarter 2008
During the quarter, over 1.7 million suspects were examined, 228,198 sputum positive cases were diagnosed, and 384,005 TB cases were registered for treatment. The annualized total case detection rate is 134 cases per 100,000 population. The new smear positive PTB case detection rate (annualized) for the 3rd quarter 2008 was 72% of the estimated cases, with a total of 154,598 new smear positive PTB cases being registered for treatment. In addition, 98,334 new smear negative PTB cases, 56,084 new extra pulmonary TB cases, 51,909 smear positive re-treatment PTB cases and 22,605 ‘Others’ were also initiated on treatment in this quarter. The treatment success rate amongst the new smear positive PTB cases registered in the 3rd quarter 2007 is 87%. The sputum conversion rate and cure rate among the new sputum positive PTB cases was 90% and 84% respectively. The default rates among the NSP (5.9%), NSN (7.4%) and re-treatment cases (14.4%) are showing declining trends. However the current default rates still remain a cause of concern.

For full report please visit: http://www.tbcindia.org/pdfs/Perf 3q08.pdf

Review Of National Tuberculosis Control Programme

LOK SABHA

Review of the programme is an ongoing activity, which is being done regularly.  The World Bank reviews the programme biannually along with other donor partners.  The last World Bank review mission came in December 2007.  In addition, the programme is reviewed externally every three years by Joint Monitoring Mission comprising of international experts from WHO, International Union Against TB and Lung Diseases (IUATLD), World Bank, DFID, Netherlands TB Association and CDC, Atlanta etc.  Such reviews took place in the years 2000, 2003 and 2006

The latest World Bank review in December 2007, observed that with case detection and treatment success rate at 70% and 84% respectively, Revised National TB Control Programme (RNTCP) has almost achieved the global targets of 70% case detection and 85% treatment outcome of smear positive cases.  This highly satisfactory result is a proof of the professionalism and dedication of RNTCP staff.  The overall progress needs now to be sustained and more attention should be devoted to poor performing districts / states still below targets.  RNTCP has also made commendable progress in challenging areas like TB/HIV collaboration where a good referral system has now been put in place.  The institutional strengthening process in Central TB Division is proceeding well and collaboration with the National Rural Health Mission (NRHM) is bearing fruit

The targets fixed by the Government during the 10th plan period for the National TB Control Programme have been achieved.  Entire country has been covered under DOTS Strategy by March 2006.  The international Joint Monitoring Mission (JMM) in October 2006, has hailed it as the fastest expansion of DOTS in the world.  The target and achievements of case detection and cure rates in 10th five year plan can be seen at Annexure.  The performance of the programme and its impact is being monitored regularly.  Till date, the RNTCP has placed more than 82 lacs patients on treatment thus saving more than 14 lacs additional lives.  As per the WHO report 2007, the death rates due to TB have declined from 42 per 100,000 population in 1990 to 29 per 100,000 population in 2005 and prevalence of tuberculosis (old and new cases) has declined from 570 cases per 100,000 population in 1990 to 299 cases per 100,000 population in 2005.  Involvement of more than 260 medical colleges, more than 2500 NGO’s, 150 corporate health facilities and more than 18000 private practitioners in the implementation of RNTCP, has increased the access of programme services.  The programme is well on its way to achieve MDGs (Millennium Development Goals) related to tuberculosis.

This information was given by the Minister for Health & Family Welfare, Dr. Anbumani Ramadoss in a reply to a question in the Lok Sabha.

KR/SK/257 – LS

ANNEXURE

Targets and Achievements under Xth Plan from 2002-2006

 

The Future of DOTS Expansion in India

In 1992, the Government of India, together with the World Health Organization (WHO) and Swedish International Development Agency (SIDA), reviewed the National TB Programme and concluded that it suffered from managerial weakness, inadequate funding, over-reliance on x-ray, non-standard treatment regimens, low rates of treatment completion, and lack of systematic information on treatment outcomes. Programme review showed that only 30% of patients were diagnosed and only 30% of those treated successfully. Based on the findings and recommendations of the review in 1992, the GOI evolved a revised strategy and launched the Revised National TB Control Programme (RNTCP) in the country. Starting in October 1993, the RNTCP was implemented in a population of 2.35 million in 5 sites in different states (Delhi, Kerala, West Bengal, Maharashtra, and Gujarat). The programme was expanded to a population of 13.85 million in 1995 and 16 million in 1996. Having proved both its technical and operational feasibility, a soft loan of US $ 142 million was negotiated with the World Bank in December 1996 and the credit agreement was signed with IDA in May 1997. It was envisaged to implement RNTCP in 102 districts of the country covering a population of 271 million in a phased manner. Another 203 SCC districts with a population of 447 million were envisaged to be strengthened as a transitional step for introduction of revised strategy at a later stage.

Having started in 1997, rapid scale-up began in late 1998, when another 100 million populations was covered under RNTCP. In the past years RNTCP has been expanding rapidly as shown below:

 

Year 1998 1999 2000 2001 2002 2003 2004 June 2005
Population Covered * 18 130 287 450 530 775 947 1028
* Cumulative, in millions

Starting in 1997, the project is being implemented in a phased manner to ensure that quality of services is maintained. Currently, more than 90% of the country’s population has been covered under the programme.

In early 2002, the TB control project was extended for another 2 years within the same budgetary provision to cover 700 million populations by 2004 under World Bank Assistance. The project is further extended for a year till September 2005 to enable coverage of the whole country as per schedule. In addition to the above, DFID and DANIDA are supporting the RNTCP to cover the entire states of Andhra Pradesh and Orissa. Global Fund for AIDS, Tuberculosis and Malaria (GFATM) are supporting DOTS expansion in 3 States of Jharkhand, Chhattisgarh, and Uttaranchal (56 million populations). In addition, the second round of GFATM covers the remaining 56 districts of Bihar and Uttar Pradesh with a population of 110 million and the fourth round of GFATM will be supporting RNTCP implementation in the states of Andhra Pradesh and Orissa once the support from DFID and DANIDA ceases. The Global Drug Facility (GDF) is providing anti-TB drugs as commodity grant for 200 million populations.

By September 2005, 604 districts/reporting units are implementing the RNTCP. 33 States and Union Territories are fully covered under the programme. GOI is continuing to take aggressive steps to meet global TB control targets by covering the entire country with RNTCP by the year 2005.

Revised National TB Control Programme and its recent progress in DOT expansion has been encouraging. As per Global TB Report 2003, 2/3rd of the additional sputum positive cases reported under DOTS in 2001, were found in India. In 2002, over 620,000 cases were placed on treatment of which nearly 250,000 were new smear positive cases. In the year 2003, more than 900,000 cases were placed on treatment. In the year 2004 alone more than 1100,000 cases were placed on treatment - largest cohort of cases, more than any other country in the world. Thus success of DOTS in India would determine the success of TB control in the world.

The treatment success rate continues to be high. 86% of the new smear positives registered in 2nd quarter 2003 were successfully treated under DOTS. The sputum conversion rate and cure among the new sputum positives was 89% and 85%, respectively.

DOTS

DOTS COVERAGE AND TREATMENT SUCCESS RATE SOARS IN INDIA

In India, which accounts for 30% of the global burden of TB, the DOTS programme is undergoing massive expansion as treatment success rates double and death rates fall. Government commitment, community involvement, and partnerships have all been key factors in the success of the DOTS programme in India.

A massive expansion of TB treatment using DOTS is today under way in India. By the end of 2002, it is planned that half the country will be covered. Eventually, it is hoped that the entire population of over one billion will have access to DOTS.

Up until late 1998, only 2% of the population were covered by DOTS. By early 1999, the number had soared to over 120 million and the numbers have been rising ever since.

The logistics involved in such rapid large-scale expansion were considerable. Over 10 000 doctors had to be trained, 2000 laboratory technicians, and 100 000 allied health workers. An additional 500 staff were employed. Almost 3000 microscopes had to be purchased and enough TB drugs to treat over 400 000 patients. Meanwhile, hundreds of thousands of technical documents had to be finalized and printed. Any future expansion will have to be phased to ensure that drug supplies, training, supervision, and monitoring can all be guaranteed. The stakes are high. India accounts for about 30% of the global burden of TB. An estimated one in two of the adult population are infected with the TB bacterium. Every year, two million people develop active tuberculosis -- more than in any other country in the world. And about 450 000 die from it -- more than the total deaths from AIDS, malaria, and tropical diseases combined.

Launched in 1993 with a series of successful small-scale pilot projects, the DOTS programme has shown continued impressive success rates. A recent analysis of the impact of the programme found that 80% of cases were successfully treated -- twice as many as in the previous TB programme. Death rates among infectious patients treated within the programme were 4%, compared with a rate over seven times higher in the non-DOTS programme.

India's DOTS programme is mainly financed through a US $ 142 million low-interest loan from the World Bank, with an increasing proportion of the costs already being met by the national and state governments. Treatment is supervised by health workers, community volunteers, traditional birth attendants, and community or religious leaders. Community workers supervise treatment for patients with limited access to a health centre. Additional staff are provided to serve difficult mountainous, tribal, and urban areas.

In order to maintain the uninterrupted supply of drugs throughout the treatment period, each patient is allocated an individual box at the outset containing the full course of treatment. This helps ensure that no patient has to stop treatment because drugs are not available, even in the event of a break in the drugs supply chain.

Ironically, India was one of the seedbeds for the global DOTS strategy, but it was many years before the idea took root there. In the 1950s, the Tuberculosis Research Centre in Chennai (formerly Madras) demonstrated that treatment observation is both necessary and feasible in the community, using intermittent treatment. In the early 1960s, India demonstrated that most TB patients did not need to be in hospital. In Madras, even destitute people living on the streets in slum areas were successfully treated with a regular supervised course of TB drugs. Meanwhile, the National Tuberculosis Institute in Bangalore demonstrated that, with minimal training and regular supervision, technicians working at the periphery could carry out sputum smear microscopy -- enabling this to become the primary tool for diagnosis of TB.

Today, as India establishes the second largest DOTS programme in the world (after China), the wheel has turned full circle. But there is still a long way to go before DOTS is available country-wide.

RNTCP PDF available

Implementation-Timeline

1992: National programme review of tuberculosis concluded that efforts to control the disease had not made any significant impact

1993: Revised National Tuberculosis Control Programme was begun, applying the principles of DOTS - which were largely discovered in India

1997: Government of India obtained a "soft" loan from the World Bank for US $142 million to implement the RNTCP in at least one third of the country and to prepare the rest of the country for implementation of RNTCP at a later date; RNTCP in Orissa is supported by the Danish Government and RNTCP in Andhra Pradesh is supported by the British Government

1999: RNTCP expands 7-fold to become the second largest such programme in the world

2001: One third of the country covered, more than 5 lakh patients treated

2002: Plan to cover half the country

The RNTCP has expanded rapidly in the past year. From a population coverage of 1.8 crore - less than 2% of the country - in 1998, by early 2001, the programme covered more than one third of the country. This represents one of the fastest expansions of this strategy anywhere in the world.

From 1.8 crore population in 1998, the RNTCP has expanded to reach 35 crore population in March 2001

Joint Review of the Tuberculosis Control Programme
To assess the performance of the RNTCP, a joint review of the tuberculosis control programme was undertaken in February 2000 by a team of 25 international and national experts. The team visited more than 100 health facilities, interviewed more than 1 000 patients and health workers, and verified the records of more than 10 000 patients. The review found that the RNTCP is succeeding and has already saved more than Rs 1 300 crore (US$ 300 million) in economic costs.

Status & Prospects
Conservative estimates are that nationwide effective DOTS implementation by 2005 would result in cumulative savings of more than Rs 108 000 crore (US$ 27 billion) through the year 2020. For an investment of Rs 200 crore (US$ 50 million) per year, the yield would be more than Rs 10 000 crore (US$ 2.5 billion) per year. Full coverage would transfer Rs 700 crore (US$ 160 million) every year to patients in medical expenses averted. By early 2001, every day 1 000 patients were being placed on treatment in the RNTCP, representing 200 lives saved and 2 000 tuberculosis infections prevented. More than 500 000 patients had been put on treatment by March 2001, saving nearly 100,000 lives and preventing more than 1 000 000 TB infections. The challenge in the years ahead is to maintain the pace and quality of the programme while achieving national coverage so that tuberculosis is no longer a significant public health problem in India.

A.R. Rahman to inaugurate TB patients network

Music director and composer A.R. Rahman Saturday launched 'TB Sangharsh', the first Indian tuberculosis patients' network, as part of a nationwide effort to create awareness about the disease here.

Inaugurating the network, Rahman, who is a global ambassador for the International Stop TB Partnership, met patients in west Delhi's Mongolpuri area. He also interacted with them about the treatments available and encouraged them to avail of these.
"Every individual is important for the country and hence it is better to be disease-free by availing of the treatment," he said.

Organised by TB Action India, a TB advocacy NGO, the programme aimes at creating awareness about the disease among the masses and involving the patients in the campaign.

The newly formed network will closely work with both NGOs and patients and advise them about different kinds of treatment available. It will also fight the stigma attached to the disease.

Stop TB Partnership is an initiative of the World Health Organisation.
Around two million people die of TB every year and about 30 percent of the world's TB population lives in India.
City pilots new TB control plan

JULY 24 MEET Channa, a science graduate who has completed a sanitary inspector’s course and is now totally dedicated to his job as a Tuberculosis Health Visitor (TBHV). His target - to cover two lakh residents of Sahakarnagar and enlist private practitioners to treat TB patients.

“I travel from 8 am till 8 pm informing community members and sensitising doctors to get involved in the Revised National Tuberculosis Control Programme,” he says about his job — one among 14 other health visitors appointed by the Pune Municipal Corporation (PMC) as part of a pilot project of the Union government’s TB division and WHO.
Pune is one of the 14 cities in the country that will involve private practitioners in the revised TB control programme, says Dr Dilip Jagtap, Secretary of the PMC TB Control Society.

The PMC’s health visitors were chosen for the six TB units of Gadikhana, Bhawani Peth, Sahakarnagar, Hadapsar, Gandhinagar and Kothrud.

So far, the results are encouraging. At least 377 private practitioners are involved in the programme. Of these, 177 work on the WHO recommended Directly Observed Treatment, Short-Course strategy or DOTS, which consists of sustained government commitment, effective laboratory-based diagnosis, standard treatment given under direct observation, secure drug supply and systematic monitoring and evaluation.

While the pilot project commenced a few months ago, Jagtap says the PMC TB control society has been encouraging private practitioners to join the programme over the last 5 years. Already two medical colleges and 25 NGO’s are involved. Henceforth, Central Government Health Scheme (CGHS) and Employees State Insurance Scheme (ESIS) will be involved with the national TB control programme.

Every year, approximately 2 million people in India develop tuberculosis, accounting for one fourth of the world’s new TB cases. In Maharashtra, Mumbai has the highest number of cases due to migrant population and overcrowding. Due to the involvement of private practitioners and other players, there has been an increase in the number of patients diagnosed with tuberculosis.

In Pune, the PMC TB Control Society diagnosed 3,876 cases in 2004. According to WHO norms, at least 160 cases of TB should be diagnosed for one lakh population.
“We are by and large meeting those norms and due to increasing private participation, the number of patients diagnosed with TB has increased in the last two quarters - over 2,350 patients have been diagnosed from January this year,’’ says Jagtap. The next step is sensitising CGHS and ESIS doctors, he adds.

Public private mix projects for TB control

Chandigarh, the capital city of the North Indian States of Punjab and Haryana is one of the fourteen cities in the country implementing pilot Public-Private-Mix (PPM) projects initiated by Revised National Tuberculosis Control Programme (RNTCP). These PPM projects launched in second half of the year 2003 are located mostly in state capitals or larger cities.

Dr. Parmod Sridhar, State TB Officer, is enthused by the promising results of PPM project in Chandigarh. Talking to TBNI he said, “Our programme caters to one million people. At any given time, we expect to have at least 900 patients on DOTS. In April 2005, 914 patients were being provided DOTS in Chandigarh and the contribution of PPM project was an impressive 314 patients.”

“When we began to sensitize private doctors we realized that it was not so easy to bring together family physicians, specialists and super-specialists on one platform for meetings or workshops,” says Sridhar, reminiscing the early days of PPM project in Chandigarh.

“PPM methodology in India provides a number of options or schemes for a range of situations. We in Chandigarh opted for schemes I and II which involve referring chest symptomatic patients (persons with cough for three weeks or more) to microscopy centers for sputum examination and working as DOTS providers respectively”, Sridhar explains.

“We were able to associate ninety-five private doctors under the first scheme. Some of them were physicians from other systems of medicine such as Ayurveda or Unani. The office bearers of local branch of Indian Medical Association (IMA), representing allopathic doctors, were initially reluctant to work with them”, he remembers.

“We explained to them that the thirteen slum colonies of Chandigarh were a priority area for our project. The number of allopathic doctors doing practice in such colonies was very low. Therefore, the people in these localities depended on physicians from other systems of medicine for health care. These physicians were an appropriate mean of reaching out to chest symptomatic patients,” says Sridhar. “It took a couple of meetings and back-up from IMA national headquarters before the local branch members agreed to work with them”, he notes with a sense of relief.

Fifty-five physicians (all of them practicing modern system of medicie) were selected as DOTS providers under the Scheme II. They included fifteen working in charitable clinics run by voluntary or community based organizations.

“Chandigarh is considered to be one of best planned cities of the country but even it has thirteen big slum colonies. We divided these in four zones. Our aim was that no patient had to travel more than two kilometers for sputum examination and one kilometer for a DOTS center. We have been largely successful on this front”, he said while providing an insight in to the planning process.

“We approached the local Municipal Corporation (MC) for financial help to appoint 13 Community Health Volunteers (CHV), so as to augment our presence in these colonies. We were lucky to get funds from MC under the Union Government’s Swaran Jayanti Shehri Rojgar Yojna (Golden Jubilee Urban Employment Plan) and now we have one CHV for approximately 30,000 to 40,000 people. They are paid Indian Rupees 1000 (US$ 24 approximately) every month. They are our watchdogs inside these communities. They help spread the messages of programme, identify newly arrived outsiders, locate addresses of the patients who leave the city and treatment midway and contact defaulting patients. No surprise the defaulter rate in Chandigarh has fallen to 2.5 percent”, he declared with a sense of satisfaction.

Dr. Sridhar has very ambitious plans for PPM project in Chandigarh, “At present one third of our patients on DOTS come from private sector, we want to gradually increase it to fifty percent and finally reach a level when two third of patients will come from non public health sources”, he asserts.

Revised National TB Control Programme (RNTCP) has accomplished
100% coverage of the country under DOTS


Union Health Minister Dr. A. Ramadoss, on the occasion of World TB Day announced that after accomplishing 100% coverage of the country under DOTS during March 2006, the Revised National TB Control Programme now aims to widen the scope for providing standardized, good quality treatment and diagnostic services to all TB patients in a patient friendly environment, in which ever health care facility they seek treatment from.

Click here to Read more



India to Implement National Action Plan against TB-HIV

India under the Revised National TB Control Programme (RNTCP) aims at widening the scope for providing standardized, good quality treatment and diagnostic services to all tuberculosis patients. It is known that about 50 - 60 % of HIV-positive people are more prone to contracting tuberculosis. Hence the Union Health and Family Welfare Minister Anbumani Ramadoss plan to tackle this issue and multi-drug resistant cases. He said this after releasing the RNTCP Status Report for India, 2006. He said that various measures are taken to tackle TB-HIV.

In the first phase, the six high-HIV prevalent States of Maharashtra, Tamil Nadu, Andhra Pradesh, Karnataka, Manipur and Nagaland were identified for implementation. The services are being provided for HIV-infected TB patients by involving Voluntary Counselling and Testing Centres and the RNTCP Designated Microscopy Centres and non-governmental organizations. The Ministry is conducting community-based surveys among new and re-treatment cases in Gujarat and Maharashtra to estimate the number of people who have become resistant for drugs.

Other states will also be strictly monitored to help the Government by observing the trends in resistance. According to the statistics drug resistance in new cases is less than 3% and in old cases it is about 10 %. Reports and data say that about 1.8 million people in India develop tuberculosis every year and nearly 3,70,000 die from it. The disease has devastating social costs. About 3 lakh children are forced to leave school because their parents have TB, and more than 1 lakh women with TB are rejected by their families every year.

The Stop TB Strategy

Vision

A WORLD FREE OF TB

Goal

To dramatically reduce the global burden of TB by 2015 in line with the Millennium Development Goals and the Stop TB Partnership targets.

Objectives
  • Achieve universal access to high-quality diagnosis and patient-centred treatment
  • Reduce the human suffering and socioeconomic burden associated with TB
  • Protect poor and vulnerable populations from TB, TB/HIV and multidrug-resistant TB
  • Support development of new tools and enable their timely and effective use

Targets

  • MDG 6, Target 8: ...halted by 2015 and begun to reverse the incidence.....
  • Targets linked to the MDGs and endorsed by the Stop TB Partnership:

    by 2005: detect at least 70% of new sputum smear-positive TB cases and cure at least 85% of these cases

    by 2015: reduce prevalence of and death due to TB by 50% relative to 1990

    by 2050: eliminate TB as a public health problem (<1 case per million population)

1. Pursue high-quality DOTS expansion and enhancement

  1. Political commitment with increased and sustained financing
  2. Case detection through quality-assured bacteriology
  3. Standardized treatment with supervision and patient support
  4. An effective drug supply and management system
  5. Monitoring and evaluation system, and impact measurement

2. Address TB/HIV, MDR-TB and other challenges

  • Implement collaborative TB/HIV activities
  • Prevent and control multidrug-resistant TB
  • Address prisoners, refugees and other high-risk groups and special situations

3. Contribute to health system strengthening

  • Actively participate in efforts to improve system-wide policy, human resources, financing, management, service delivery, and information systems
  • Share innovations that strengthen systems, including the Practical Approach to Lung Health (PAL)
  • Adapt innovations from other fields

 

4. Engage all care providers

  • Public-Public, and Public-Private Mix (PPM) approaches
  • International Standards for Tuberculosis Care (ISTC)

5. Empower people with TB, and communities

  • Advocacy, communication and social mobilization
  • Community participation in TB care
  • Patients' Charter for Tuberculosis Care

6. Enable and promote research

  • Programme-based operational research
Research to develop new diagnostics, drugs and vaccines

Haryana under revised national TB control programme

June 8, 2009

Chandigarh (PTI): Haryana has been fully covered under Revised National Tuberculosis Control Programme and Directly Observed Treatment (DOT) Plus Programme has been introduced to treat multi drug resistant TB patients, a senior official said on Monday.

The cost of treatment of a multi drug resistant TB patient comes to be around Rs 1 lakh which is free of cost in Haryana under Revised National Tuberculosis Control Programme, Haryana's Financial Commissioner and Principal Secretary, Health Anuradha Gupta said on Monday, according to an official release here.

She said that Haryana is among first five states in the country to provide DOT Plus Programme. Other four such states are Gujarat, Maharashtra, Andhra Pradesh and New Delhi.

She said that the State Health Department has taken a number of steps to make Haryana free from Tuberculosis, which is a major health problem in India caused by Mycobacterium tuberculosis.

"Those suffering from TB have access to the highly effective Directly Observed Treatment Strategy (DOTS). The Government is providing free sputum microscopy facilities and medicines to patients in six to eight months' regimens. There were more than 5,800 Directly Observed Treatment Centers, 215 Microscopic Centers and 47 TB Units functioning in the State," she added.

She said that in the first phase of DOTS Plus programme, seven districts--Panipat, Sonepat, Jind, Karnal, Jhajjar, Rohtak and Bhiwani have been covered and the remaining districts would be covered in the second phase of the programme.

Source: hinduonnet.com

 

Second phase of TB therapy in central Gujarat soon

Jul 12, 2009

The second phase of identifying Multidrug-Resistant Tuberculosis (MDR-TB) patients will soon be implemented in seven districts of central Gujarat. These are Vadodara rural, Vadodara city, Chhota Udepur, Dahod, Panchmahals, Bharuch and Narmada.

Gandhinagar, Mehsana, Nadiad, Anand, Banaskantha, Sabarkantha and Surendranagar districts of north Gujarat were covered under the first phase of Directly Observed Therapy Short-Course (DOTS) Plus programme under the Revised National Tuberculosis Control Programme (RNTCP).

For the first time, the patients will be introduced to DNA diagnosis technique to diagnose MDR-TB. According to the World Health Organization (WHO), drug resistance is regarded as one of the major deterrents in the eradication of tuberculosis.

Three states, including Gujarat, are undertaking the pilot project of implementing the second line treatment of DOTS. But instead of the four-month wait for TB diagnosis, the evaluation will be completed in only eight hours with the DNA diagnosis technique.

The Sir Sayajirao General Hospital (SSG) has been chosen as the nodal centre for the second phase, which will start within the next few months.

Dr Kiran Rami, associate professor, department of TB and Chest Disease, Sir Sayajirao General Hospital (SSG), said, “We have designated a ward for project where the patients will be kept under constant observation and will be monitored for the side-effects associated with the DOTS Plus treatment.”

At present, over one lakh TB patients are registered with RNTCP and an estimated 2,000 are multi-drug resistant in need of second line treatment of DOTS-Plus.
WHO TB consultant Kiran Rade said: “The project will start with identifying MDR-TB patients which will be followed by a complete evaluation of their physical, medical and psychological state. They have to be counselled for 24 month treatment and also of the side effects.”

Source: indianexpress.com

 

Testing for Tuberculosis in The Slums of New Dehli

11 September, 2009

Nina Jain ’11 spent last summer trekking door-to-door through a Delhi slum, trying to find out which of the impoverished residents suffered from tuberculosis. There was one problem, though. She didn’t speak Hindi.

“I memorized the questions in Hindi, and asked them to say yes or no,” she said. “I had a translator, but she didn’t speak English.”

Jain worked with Asha, an organization that focuses on community health and development, a non-governmental organization that works toward the education of underprivileged children.


“It focuses a lot on empowering the people in the slums so they can take control of their own lives and improve their socioeconomic status,” Jain said.

Asha has only been present for the past four years in the slum where Jain worked, and so many diseases and health problems are still rooted in the population, Jain said.

“I went from house to house and went through a list of symptoms for TB,” she said. “If they were suffering from a lot of the symptoms, we would give them a test and find out two days later if they were positive.”

The infected patients could then be treated at the clinic or by a doctor who visited the slums weekly, added Jain.

Jain also worked with children living in the slums to teach them English. Although many of the students took English classes in free, government-run schools, Jain said that many could not even say, “Hello, my name is…”

“The saddest thing about being so poor is not that you don’t have enough clothes to wear or that you don’t have as many things as somebody else,” Jain said. “It’s that you don’t have any opportunities, you have no chances to get yourself out of this position, and you don’t even know what’s available to you.”

Despite the debilitating conditions, Asha has managed to get 200 students into universities this past year, Jain said. To help them with study skills and assimilating to college social life, she held workshops for the students.

“They’re so brave—they’ve never left the slum and now they’re going to college and they weren’t afraid,” said Jain. “It was unbelievable.”

Jain was supported by the Harvard South Asian Men’s Collective (SAMC), which has previously raised money for Asha and awards a SAMC-Asha Fellowship, according to SAMC Chair Roy V. Mathew ’10.

“We’re really excited to have people have a sustainable impact and maintain a long-term relationship with Asha,” Mathew said.

Source: thecrimson.com

 

 
Feedback | Legal Disclaimer
 
 

An initiative in India by Sandoz Business Unit
Copyright© 2004, All rights reserved

 
Site developed and maintained by E Vision Technologies